Controlling Plasma Stability of Hydroxamic Acids: A MedChem Toolbox

Archive ouverte

Hermant, Paul | Bosc, Damien | Piveteau, Catherine | Gealageas, Ronan | Lam, Baovy | Ronco, Cyril | Roignant, Matthieu | Tolojanahary, Hasina | Jean, Ludovic | Renard, Pierre-Yves | Lemdani, Mohamed | Bourotte, Marilyne | Herledan, Adrien | Bedart, Corentin | Biela, Alexandre | Leroux, Florence | Deprez, Benoit | Déprez-Poulain, Rébecca, F.

Edité par CCSD ; American Chemical Society -

International audience. Hydroxamic acids are outstanding zinc chelating groups that can be used to design potent and selective metalloenzyme inhibitors in various therapeutic areas. Some hydroxamic acids display a high plasma clearance resulting in poor in vivo activity, though they may be very potent compounds in vitro. We designed a 57-member library of hydroxamic acids to explore the structure-plasma stability relationships in these series and identify both which enzyme(s) and which pharmacophores are critical for plasma stability. Arylesterases and carboxylesterases were identified as the main metabolic enzymes for hydroxamic acids. Finally, we suggest structural features to be introduced or removed to improve stability. This work provides thus the first medicinal chemistry toolbox (experimental procedures and structural guidance) to assess and control the plasma stability of hydroxamic acids and realize their full potential as in vivo pharmacological probes and therapeutic agents. This study is particularly relevant to preclinical development as it allows to obtain compounds equally stable in human and rodent models.

Suggestions

Du même auteur

Discovery of the First Selective Nanomolar Inhibitors of Endoplasmic Reticulum Aminopeptidase 2 by Kinetic Target‐Guided Synthesis

Archive ouverte | Camberlein, Virgyl | CCSD

International audience

Drug Target Engagement using coupled Cellular Thermal Shift Assay -acoustic Reverse Phase Protein Array

Archive ouverte | Herledan, Adrien | CCSD

International audience. In the last 5 years, cellular thermal shift assay (CETSA), a technology based on ligand-induced changes in protein thermal stability, has been increasingly used in drug discovery to address t...

Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice

Archive ouverte | Déprez-Poulain, Rebecca | CCSD

International audience. Insulin-degrading enzyme (IDE) is a protease that cleaves insulin and other bioactive peptides such as amyloid-β. Knockout and genetic studies have linked IDE to Alzheimer's disease and type-...

Chargement des enrichissements...